This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Abo Akademi. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: John Elias Eriksson: Innovator in HPV-Induced Carcinoma Treatment
Introduction
John Elias Eriksson is a notable inventor based in Åbo, Finland. He has made significant contributions to the field of medical research, particularly in the treatment of HPV-induced carcinoma. His innovative work has led to the development of a unique compound that holds promise for cancer treatment.
Latest Patents
Eriksson holds a patent for "Compounds for the treatment of HPV-induced carcinoma," specifically a compound of Formula 1. This patent represents a crucial step forward in addressing a serious health issue affecting many individuals worldwide.
Career Highlights
Eriksson is affiliated with Abo Akademi, where he continues to engage in groundbreaking research. His work at the university has allowed him to explore various avenues in medical science, contributing to advancements in cancer treatment.
Collaborations
Throughout his career, Eriksson has collaborated with talented individuals such as Senthil Kumar Rajendran and Preethy Paul. These partnerships have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
John Elias Eriksson is a dedicated inventor whose work in developing compounds for HPV-induced carcinoma showcases his commitment to improving healthcare. His contributions are vital in the ongoing fight against cancer, and his innovative spirit continues to inspire others in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile